US Patent Issued to FORMA Therapeutics on Oct. 28 for "Inhibiting cyclic AMP-responsive element-binding protein (CREB) binding protein (CBP)" (Michigan, Connecticut Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,532, issued on Oct. 28, was assigned to FORMA Therapeutics Inc. (Watertown, Mass.).

"Inhibiting cyclic AMP-responsive element-binding protein (CREB) binding protein (CBP)" was invented by George Luke (Clinton, Conn.) and Suresh Babu (Ypsilanti, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to solid and salt forms of inhibitors of the CBP/p300 family of bromodomains made up of salts and crystalline forms of Formula (I). The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compo...